中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 1
Jan.  2014
Turn off MathJax
Article Contents

Current development of liver transplantation in China

DOI: 10.3969/j.issn.1001-5256.2014.01.001
  • Received Date: 2013-10-24
  • Published Date: 2014-01-20
  • As the only effective way for the treatment of end- stage liver disease, liver transplantation has been developed rapidly in China over recent years. The latest developments of liver transplantation in China are reviewed, including establishment of selection criteria for the liver cancer recipients of liver transplantation——Hangzhou Criteria; latest application of salvage liver transplantation and downstaging therapy in liver transplantation for liver cancer; progress in liver transplantation combined with artificial liver support system for treatment of severe acute liver failure; breakthrough in technology innovation of living donor liver transplantation and organ donation and transplantation after cardiac death in China. Facing the problem of organ shortage, a scientific and standardized organ donation system should be established in line with the national conditions of China, so as to benefit the people and further improve the reputation of China in the international organ transplant community.

     

  • loading
  • [1] STARZL TE, MARCHIORO TL, VONKAULLA KN, et al.Homotransplantation of the liver in humans[J].Surg Gynecol Obstet, 1963, 117:659-676.
    [2] STARZL TE.The long reach of liver transplantation[J].Nat Med, 2012, 18 (10) :1489-1492.
    [3] MAZZAFERRO V, REGALIA E, DOCI R, et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J].N Engl J Med, 1996, 334 (11) :693-699.
    [4]ZHENG SS, XU X, WU J, et al.Liver transplantation for hepatocellular carcinoma:Hangzhou experiences[J].Transplantation, 2008, 85 (12) :1726-1732.
    [5]FAN ST.Selection of HCC patients for liver transplantation:the Milan criteria, Hangzhou criteria and beyond[J].Hepatobiliary Pancreat Dis Int, 2008, 7 (3) :233-234.
    [6]AUDET M, PANARO F, PIARDI T, et al.Are the Hangzhou Criteria adaptable to hepatocellular carcinoma patients for liver transplantation in western countries?[J].Liver Transpl, 2009, 15 (7) :822-823.
    [7]HU Z, ZHOU J, XU X, et al.Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection[J].PLoS One, 2012, 7 (5) :e36587.
    [8]LEI J, YAN L.Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies[J].J Gastrointest Surg, 2013.[Epub ahead of print]
    [9]LEE WM, STRAVITZ RT, LARSON AM.Introduction to the revised American association for the study of liver diseases position paper on acute liver failure 2011[J].Hepatology, 2012, 55 (3) :965-967.
    [10]CHAN G, TAQI A, MAROTTA P, et al.Long-term outcomes of emergency liver transplantation for acute liver failure[J].Liver Transpl, 2009, 15 (12) :1696-1702.
    [11]XU X, LIU X, LING Q, et al.Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure[J].PLoS One, 2013, 8 (3) :e58738.
    [12]LING Q, XU X, WEI Q, et al.Downgrading MELD improves the outcomes after liver transplantation in patients with acute-onchronic hepatitis B liver failure[J].PLoS One, 2012, 7 (1) :e30322.
    [13] WU J, WANG W, ZHANG M, et al.Reconstruction of middle hepatic vein in living donor liver transplantation with modified right lobe graft:a single center experience[J].Transpl Int, 2008, 21 (9) :843-849.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2739) PDF downloads(748) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return